Molecular imaging 'probes' pinpoint prostate cancer

Molecular imaging has a powerful new weapon in the fight against prostate cancer. Research demonstrates how a novel peptide-targeted imaging agent could help clinicians detect a biological process that signals cancer in prostate cells. Information gathered about this process may even differentiate prostate tumor types and the progression of disease.

Read the whole article on Science Daily

More from Science Daily